| |
|
|
|
Matinas Biopharma Hl  
|
|
0.8991 0.009 (0.01%) |
06-02 16:00 |
|
Open: |
0.89 |
Pre close: |
0.89 |
Target:
|
1.16
|
|
High: |
0.94 |
Low: |
0.882 |
Resistance:
|
0.99
1.16
|
|
Volume: |
1,742,629 |
Market Cap: |
178M |
Support:
|
0.77
0.64
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.90
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
0.81  |
Signal(12,26,9): |
0.04 |
|
MA(100): |
0.96 |
Stochastic Oscillator |
%K(14,3):
|
70.05 |
|
MA(250): |
0.96 |
%D(3): |
72.44 |
|
Average Volume(K) |
3-Month: |
196874
|
52-Week |
High:
|
2.49 |
|
10-Days: |
218925 |
Low: |
0.49 |
|
RSI |
RSI(14):
|
63.35 |
Change(%): |
-2.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.117 |
Return on Equity (ttm) |
-30.5 |
Shares Out. (M) |
197.49 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-19.6 |
Shares Float (M) |
159.09 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.55 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.78 |
|
Forward EPS |
-0.150 |
Gross Profit (p.s.) |
-0.056 |
Shares Short (K) |
14520 |
|
Book Value (p.s.) |
0.370 |
EBITDA (p.s.) |
-0.106 |
P/E |
-7.68 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.43 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.73 |
P/S |
1977.10 |
|
Operating Margin |
-23565.26 |
Levered Free Cash Flow
(M) |
-12.07 |
P/CF |
-11.29 |
|
|
|
|
|
|
